![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
ET Iwamoto and L Marion
Department of Pharmacology, University of Kentucky College of Medicine, Lexington.
This study was designed to determine if the antinociception produced by intrathecally (i.t.) administered muscarinic agonists in male Sprague- Dawley rats is mediated by an L-arginine/nitric oxide/cyclic GMP cascade. Seven days after implantation of intrathecal catheters, antinociception was produced with graded doses of (+)-cis- methyldioxolane (CD). The ED50 values for CD in the hot-plate and tail- flick tests were 2.6 and 2.0 nmol, respectively. The corneal and righting reflexes, as well as stepping and negative geotaxic responses, were not affected by CD. Six-minute pretreatment with 50 nmol of the nitric oxide synthase inhibitor L-NG-nitroarginine (NNR) significantly inhibited CD-produced hot-plate and tail-flick antinociception as evidenced by 6-fold shifts to the right of the CD dose-response curves. Coadministration of 150 nmol of L-arginine with NNR reversed the NNR- induced inhibition of the antinociception produced by CD. D-Arginine was without effect. Pretreatment with 500 nmol of the guanylyl cyclase inhibitor methylene blue also antagonized the antinociception produced by CD in both the hot-plate and tail-flick tests. In parallel with CD, coadministration of L-arginine with NMR reversed the NMR-induced inhibition of (+)-muscarine-produced antinociception in both nociceptive tests. Intrathecal administration of buffer, 50 nmol of NNR, 150 nmol of L- or D-arginine or 500 nmol of methylene blue, did not alter nociceptive responses when injected alone. In contrast, i.t. administration of the membrane-permeable cyclic GMP analogs, dibutyryl cyclic GMP and 8-bromo cyclic GMP, produced antinociception in both nociceptive tests when injected alone.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  S.-R. Chen and H.-L. Pan Up-Regulation of Spinal Muscarinic Receptors and Increased Antinociceptive Effect of Intrathecal Muscarine in Diabetic Rats J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 676 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Dunbar and I. G. Karamian Cross-tolerance between spinal neostigmine and morphine in the rat Br. J. Anaesth., September 1, 2003; 91(3): 427 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Khan, D.-P. Li, S.-R. Chen, and H.-L. Pan Role of Spinal Nitric Oxide in the Inhibitory Effect of [D-Pen2, D-Pen5]-Enkephalin on Ascending Dorsal Horn Neurons in Normal and Diabetic Rats J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1021 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Turan, B. Karamanlyoglu, D. Memis, G. Kaya, and Z. Pamukcu Intravenous Regional Anesthesia Using Prilocaine and Neostigmine Anesth. Analg., November 1, 2002; 95(5): 1419 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Xu, C. Tong, H.-L. Pan, S. E. Cerda, and J. C. Eisenach Intravenous Morphine Increases Release of Nitric Oxide From Spinal Cord by an alpha -Adrenergic and Cholinergic Mechanism J Neurophysiol, October 1, 1997; 78(4): 2072 - 2078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Machelska Inhibition of Nitric Oxide Synthase Enhances Antinociception Mediated by Mu, Delta and Kappa Opioid Receptors in Acute and Prolonged Pain in the Rat Spinal Cord J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 977 - 984. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
